Reaction

Congenital Cytomegalovirus Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 146 reports · 6 co-occurring drugs

As of the last recalculation, Congenital Cytomegalovirus Infection appears in 146 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 239.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Valganciclovir Hydrochloride Powder,	18	239.8	240.2
Cefuroxime	14	193.0	193.2
Valganciclovir	20	175.1	175.3
Valganciclovir Hydrochloride	20	175.1	175.3
Zidovudine	13	152.0	152.2
Cabotegravir	4	72.6	72.6

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.